PATH is a global organization that works to accelerate health equity by bringing together public institutions, businesses, social enterprises, and investors to solve the world’s most pressing health challenges. With expertise in science, health, economics, technology, advocacy, and dozens of other specialties, PATH develops and scales solutions—including vaccines, drugs, devices, diagnostics, and innovative approaches to strengthening health systems worldwide.
PATH’s work on vaccine development and introduction encompasses activities including discovery, preclinical development, process development and manufacturing, regulatory, clinical research and development, and including vaccine introduction and sustainability. Over 25 candidates and vaccines are currently in our portfolio in the following disease areas—Malaria, Enteric and Diarrheal Diseases, Polio, Respiratory Tract Infections and Meningitis, HPV and Vector-borne viral diseases (e.g., Japanese Encephalitis)—and in the cross-cutting area of Maternal Immunization. The Center for Vaccine Innovation and Access (CVIA) within PATH is advancing immunization equity and vaccination coverage to reduce vaccine preventable diseases through increasing and improving accessibility, affordability, availability, acceptability, and sustainability of essential existing and new vaccines for routine immunization and pandemic/epidemic preparedness.
Reporting to the Vice-President of PATH Essential Medicines and the Head of CVIA, the Global Head of Clinical provides leadership and management to the Clinical Functional area. This functional area provides the technical expertise, operational excellence and leadership in the clinical science of infectious diseases and is responsible for conceiving and bringing to realization all technical plans to conduct studies in humans, inclusive of Experimental Medicine through Phase 5 studies; clinical research, science, operations, quality, data management, and statistics. The Global Head of Clinical is an integral partner on the Center for Vaccine Innovation and Access (CVIA) leadership team as a change leader, strategy creator, proactive partner in developing comprehensive cross-disciplinary tactics and an enabler of exceptional execution through cross-group collaboration.
Provides scientific and technical leadership for Clinical Development and Pharmacovigilance of across the PATH EM portfolio.
Oversee Clinical functional activities and clinical aspects of project team work to ensure compliance with PATH policies and procedures and international standards (e.g., cGCP).
Member of the CVIA leadership team partnering with other leadership team members to support the goals and objectives of vaccine development and introduction.
Develop strong partnerships across the CVIA leadership team to ensure overall integrated development and introduction tactics for CVIA projects.
Sponsor CVIA-wide and Clinical area-specific change management activities and express, model, and reinforce desired behaviors.
Provide overall strategy for the clinical functional area within CVIA inclusive of risk assessment and regulatory pathways (the latter in collaboration with the Global Head, Regulatory).
Oversee the PATH EM Scientific Merit Review process to ensure that investigational evaluation through human subjects research (HSR) conducted on essential medicines is scientifically meritorious and that the design, operations, risk management of the study and study protocol, and informed consent language regarding study-related injury, investigator brochure, and other clinical functional area elements related to the HSR are fit-for-purpose
Lead the development and creation of norms, processes, standards, and documentation to ensure highest quality of clinical research and operations support to projects with a strong scientific component.
Manage the clinical team to develop and review clinical development plans, protocols and amendments, investigator brochures, clinical sections of IND/IMPD filings, clinical study reports, and manuscripts.
Provide clinical safety oversight, including development of risk management plans and ongoing review of safety in clinical trials and post-authorization pharmacovigilance.
Evaluate safety, immunogenicity, and efficacy data from ongoing and completed human clinical studies (experimental medicine through Phase 5).
Ensure understanding and ability to evaluate clinical assay performance, including analytical and clinical validation.
Serves as the primary contact with PATH’s Center of Digital Excellence (CoDE) and drives the transformation and innovation in integrating data and digital in all the clinical work with PATH EM and sharing a visionary approach and distinctive capabilities with funders.
Interact with partners to provide input, oversight, guidance, and evaluations of clinical development plans.
Review manuscripts, abstracts, and presentations for scientific meetings.
Ensure the expected results of various activities are clear, measurable, and consistent with PATH policies and mission.
Ensure compliance with PATH policies and procedures and international standards (e.g., GCPs, ethical standards).
Lead interactions with global health authorities and partners.
Ensure timely and adequate talent resource allocation across vaccine development projects and activities.
Recruit, supervise, coach, and develop staff.
15+ years of industry or field vaccine clinical research and development; industry experience preferred.
Bachelor’s degree in a scientific discipline and an advanced degree (e.g., MD, DO, DVM, PhD). Substantial experience in medical research (basic, applied and/or field research), preferable in infectious diseases.
Demonstrated clinical development experience designing clinical study plans as well as integrated product development and lifecycle management plans in a global setting.
Experience and success in conducting clinical studies on a global scale, particularly in low income countries (i.e., multi-center studies conducted in multiple geographies).
Preference for public health experience.
Internationally recognized clinical expert (with scientific/medical recognition) who has demonstrated ability to interact productively with and attract top external investigators.
Demonstrated personnel leadership and management skills at a senior management level, namely recruiting and hiring staff and consultants; coaching, mentoring and developing employees; and teaching core values and upholding professional culture.
Reputation as a flexible team player with ability to forge consensus in a project-focused matrix organization and align with various other vaccine leaders.
Sensitive to the health needs of impoverished countries proven by career experience developing successful partnerships resulting in important public health advances.
Experience sponsoring change management initiatives across a balanced matrix organization.
Able to operate and adapt successfully in an ambiguous and frequently changing environment.
Demonstrated senior management level capacity to manage diverse and varied job responsibilities.
Outstanding technical, written, verbal, and interpersonal communication skills.
Prefer global management experience across multiple time zones and cultures.
Domestic and international travel up to 30% annually.
PATH is dedicated to building an inclusive workforce where diversity is valued.
PATH is an equal opportunity employer. Every qualified applicant will be considered for employment. PATH does not discriminate based on race, color, religion, gender, sexual orientation, gender identity, genetic information, age, national origin, marital status, disability status, political ideology, military or protected veteran status, or any other characteristic protected by applicable federal, state, or local law.
*PATH has become aware of scams involving false job offers.*
PATH will never ask for a fee during any stage of the recruitment process.
All active jobs are advertised directly on our career's page.
Official PATH emails will always arrive from an @path.org or @silkroad.com email address.
Please report any suspicious communications to firstname.lastname@example.org.